European Journal of Molecular & Clinical Medicine

Background:  Sclerotherapy and endovenous laser ablation (EVLA) have emerged as alternative treatments to surgery for patients with varicose veins, but uncertainty exists regarding their effectiveness in the medium to longer term.
Objectives: To compare the clinical effectiveness, outcome, complications, recurrence and post operative improvement in CEAP classification in patients treated with EVLA and Sclerotherapy .
Methods: This is a prospective study. All patients fulfilling inclusion criteria with varicose veins  in Krishna Hospital & Medical Research Centre, Karad will be included in the study
Results:  More than 80% of the study population was classified as C2 or C3 venous disease. After 1 and 1/2  year, the anatomic success rate was highest after EVLA , followed by sclerotherapy. The complication rate was low and comparable between treatment groups. All groups showed significant (P < .001) improvement of quality of life and Chronic Venous Insufficiency  72.10%  of patients with  C2 class showed an improvement of the "C" of the CEAP classification.
Conclusion: Endovenous ablation therapy has shown high improvement with the outcomes such as hospital stay, or post operative complications.It can be concluded that the endovenous ablation therapy is an effective method to cure varicose vein which taken significantly higher time for complication of the wound.Compared to sclerotherapy, and apart from signs and symptoms endovenous ablation therapy is an effective therapy which should be used in the management of varicose veins.